RENAL FUNCTIONAL RESERVE IN CYCLOSPORINE-TREATED RECIPIENTS OF KIDNEY-TRANSPLANT

被引:24
|
作者
ADER, JL [1 ]
TACK, I [1 ]
LLOVERAS, JJ [1 ]
TRANVAN, T [1 ]
ROSTAING, L [1 ]
PRADDAUDE, F [1 ]
DURAND, D [1 ]
SUC, JM [1 ]
机构
[1] CHU RANGUEIL,SERV NEPHROL & TRANSPLANTAT,F-31054 TOULOUSE,FRANCE
关键词
D O I
10.1038/ki.1994.217
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The aims of this study were to determine whether renal functional reserve (RFR) is still present in cyclosporin-treated renal transplant recipients, and to examine the relationship between RFR and proximal reabsorption. A serial study was carried out in 12 renal allograft recipients (R) with good renal graft function at 20 +/- 2.5 days (S1) and at 7.6 +/- 0.4 months (S2) post-transplantation, and the results were compared to those in eight subjects who had undergone uninephrectomy (one-kidney controls: UNx.C) and in 12 healthy volunteers (two-kidney controls: 2K.C). R and C were in similar sodium and protein balance and with similar plasma renin and aldosterone levels. R had normal serum creatinine lever on moderate doses of cyclosporin (whole blood cyclosporin concentration: 212 +/- 20 and 125 +/- 20 ng/ml at S1 and S2, respectively). Eight one-hour clearance periods were performed prior to, during and following a three-hour i.v. infusion of a mixture of 20 l-amino acids (Azonutril 25(R), 4.5 mg amino acids/kg/min). Baseline glomerular filtration rate (GFR) was lower in recipients at S1 and S2 (55 +/- 5 and 54 +/- 4 ml/min/1.73 m(2), respectively) than in UNx.C and 2K.C (72 +/- 4 and 113 +/- 4 ml/min/1.73 m(2), respectively, P < 0.05 and 0.001). Amino acid infusion elicited significant GFR increases in controls as well as in recipients in spite of higher renal vascular resistances (RVR). The greater measured increase in GFR, which represented RFR, was 18 +/- 3 and 28 +/- 2 ml/min/1.73 m(2) in UNx.C and 2K.C, respectively (P < 0.001), and 17 +/- 3 ml/min/1.73 m(2) in R at both S1 and S2 (P < 0.001). Contrary to both UNx and 2K controls, the acute hyperfiltration in R at S1 and S2 occurred with a significant increase in effective renal plasma how, no alteration in filtration fraction and a large decrease (approximately 20 and 17%) in RVR while no correlation could be detected between the RFR and baseline GFR. Baseline lithium clearance, used as a marker of overall proximal fluid delivery (C-Li, was significantly lower, whereas baseline fractional excretion of lithium (FE(Li)) was significantly higher in R at S1 and S2 and in UNx.C (41 +/- 4, 40 +/- 3 and 38 +/- 3%, respectively) than in 2K.C (31 +/- 2%, P < 0.05). Consistent and significant increases in C-Li, FE(Li) and absolute proximal reabsorption occurred both in R at S1 and S2 and in UNx and 2K controls during elicitation of RFR. These results indicate that: (1) renal graft recipients maintained on cyclosporin therapy do not exhibit permanent glomerular hyperfiltration, since they retain a RFR until at least eight months post-transplantation which represents approximately 30% of the baseline GFR but do, however, demonstrate a particular pattern of hemodynamic response; (2) in one-kidney recipients and controls, the clearance of lithium is proportionally less reduced than GFR, and baseline fractional proximal reabsorption is thus lower than in two-kidney controls; and, (3) the acute increase in GFR induced by amino acid infusion does not involve a decrease in delivery of fluid from the proximal nephron that could account for any possible reduction in the tubuloglomerular feedback activity.
引用
收藏
页码:1657 / 1667
页数:11
相关论文
共 50 条
  • [41] RENAL EFFECTS OF L-ARGININE INFUSION IN CYCLOSPORINE-TREATED TRANSPLANT RECIPIENTS
    VIGANO, E
    BADALAMENTI, S
    PAONE, G
    COMO, G
    FINAZZI, S
    TARANTINO, A
    GALMARINI, D
    PONTICELLI, C
    [J]. TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 2622 - 2623
  • [42] POSTTRANSPLANT DIABETES-MELLITUS IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS
    SUMRANI, N
    DELANEY, V
    DING, Z
    DAVIS, R
    DASKALAKIS, P
    FRIEDMAN, EA
    BUTT, KM
    HONG, JH
    [J]. TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1249 - 1250
  • [43] Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients
    Kahan, BD
    Yakupoglu, YK
    Schoenberg, L
    Knight, RJ
    Katz, SM
    Lai, D
    Van Buren, CT
    [J]. TRANSPLANTATION, 2005, 80 (06) : 749 - 758
  • [44] Renal functional reserve in kidney and heart transplant recipients
    Ader, JL
    Tack, I
    Durand, D
    TranVan, T
    Rostaing, L
    Suc, JM
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (08): : 1145 - 1152
  • [45] Substantially elevated levels of atorvastatin and metabolites in cyclosporine-treated renal transplant recipients
    Hermann, M
    Åsberg, A
    Christensen, H
    Holdaas, H
    Hartmann, A
    Reubsaet, JLE
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (04) : 388 - 391
  • [46] HYPERTENSION IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS IS SODIUM-DEPENDENT
    CURTIS, JJ
    LUKE, RG
    JONES, P
    DIETHELM, AG
    [J]. AMERICAN JOURNAL OF MEDICINE, 1988, 85 (02): : 134 - 138
  • [47] VARIABLES AFFECTING BIRTH-WEIGHT AND GRAFT-SURVIVAL IN 197 PREGNANCIES IN CYCLOSPORINE-TREATED FEMALE KIDNEY-TRANSPLANT RECIPIENTS
    ARMENTI, VT
    AHLSWEDE, KM
    AHLSWEDE, BA
    CATER, JR
    JARRELL, BE
    MORITZ, MJ
    BURKE, JF
    [J]. TRANSPLANTATION, 1995, 59 (04) : 476 - 479
  • [48] CLINICAL-EVALUATION OF TROUGH LEVELS AND AREA-UNDER-THE-CURVE IN CYCLOSPORINE-TREATED AND FK-506-TREATED KIDNEY-TRANSPLANT RECIPIENTS
    TAKAHARA, S
    KOKADO, Y
    KAMEOKA, H
    TAKANO, Y
    MOUTABARRIK, A
    JIANG, H
    ISHIBASHI, M
    OKUYAMA, A
    NISHI, Y
    CHIBA, N
    SONODA, T
    [J]. TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 2802 - 2806
  • [49] Safety of Eplerenone for Kidney-Transplant Recipients with Impaired Renal Function and Receiving Cyclosporine A
    Bertocchio, Jean-Philippe
    Barbe, Coralie
    Lavaud, Sylvie
    Toupance, Olivier
    Nazeyrollas, Pierre
    Jaisser, Frederic
    Rieu, Philippe
    [J]. PLOS ONE, 2016, 11 (04):
  • [50] FENOLDOPAM REVERSES CYCLOSPORINE-INDUCED RENAL VASOCONSTRICTION IN KIDNEY-TRANSPLANT RECIPIENTS
    JORKASKY, DK
    AUDET, P
    SHUSTERMAN, N
    ILSON, B
    DAFOE, D
    HEDRICH, D
    STOTE, RM
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (06) : 567 - 572